CellNet - Where your cells are standing

Kee Pyo Kim; Hans R. Schöler

doi:10.1016/j.cell.2014.08.001

CellNet - Where your cells are standing

Kee Pyo Kim
, Hans R. Schöler

Department of Biomedicine & Health Science

Max Planck Institute for Molecular Biomedicine

Research output: Contribution to journal › Short survey › peer-review

5 Scopus citations

Abstract

The manufacturing of clinically relevant cells is a widely used strategy in regenerative medicine. Cahan et al. develop a network biology platform named CellNet to accurately assess the fidelity of such cells and spot aberrant regulatory networks, and Morris et al. apply this platform to improve cell manufacturing.

Original language	English
Pages (from-to)	699-701
Number of pages	3
Journal	Cell
Volume	158
Issue number	4
DOIs	https://doi.org/10.1016/j.cell.2014.08.001
State	Published - 14 Aug 2014

Access to Document

10.1016/j.cell.2014.08.001

Cite this

@article{3fbbc1cb865f47b590d092ea7c15e8b9,

title = "CellNet - Where your cells are standing",

abstract = "The manufacturing of clinically relevant cells is a widely used strategy in regenerative medicine. Cahan et al. develop a network biology platform named CellNet to accurately assess the fidelity of such cells and spot aberrant regulatory networks, and Morris et al. apply this platform to improve cell manufacturing.",

author = "Kim, \{Kee Pyo\} and Sch{\"o}ler, \{Hans R.\}",

year = "2014",

month = aug,

day = "14",

doi = "10.1016/j.cell.2014.08.001",

language = "English",

volume = "158",

pages = "699--701",

journal = "Cell",

issn = "0092-8674",

publisher = "Elsevier B.V.",

number = "4",

}

TY - JOUR

T1 - CellNet - Where your cells are standing

AU - Kim, Kee Pyo

AU - Schöler, Hans R.

PY - 2014/8/14

Y1 - 2014/8/14

N2 - The manufacturing of clinically relevant cells is a widely used strategy in regenerative medicine. Cahan et al. develop a network biology platform named CellNet to accurately assess the fidelity of such cells and spot aberrant regulatory networks, and Morris et al. apply this platform to improve cell manufacturing.

AB - The manufacturing of clinically relevant cells is a widely used strategy in regenerative medicine. Cahan et al. develop a network biology platform named CellNet to accurately assess the fidelity of such cells and spot aberrant regulatory networks, and Morris et al. apply this platform to improve cell manufacturing.

UR - https://www.scopus.com/pages/publications/84908401109

U2 - 10.1016/j.cell.2014.08.001

DO - 10.1016/j.cell.2014.08.001

M3 - Short survey

C2 - 25126778

AN - SCOPUS:84908401109

SN - 0092-8674

VL - 158

SP - 699

EP - 701

JO - Cell

JF - Cell

IS - 4

ER -

CellNet - Where your cells are standing

Abstract

Access to Document

Other files and links

Fingerprint

Cite this